Über Markus
- Scope, intended purpose and equivalence framing
- Clinical evidence identification and appraisal
- Safety and performance acceptance criteria set against the state of the art
- Clinical data gap analysis
- Benefit–risk conclusions consistent with the risk management file and IFU
- PMCF plans and study design where required
- PMS data analysis and PSUR/PMS report authoring
- Integration of post-market findings back into the CER and risk management file
Deutsch
Muttersprachlich oder zweisprachig
Englisch
Verhandlungssicher
Projekt- und Berufserfahrung
- Croma-Pharma GmbH,Regulatory Affairs & Medical Writing ManagerOktober 2022 - Heute (3 Jahre und 10 Monate)AustriaSubject matter expert responsible for authoring regulatory documentation for EU and international submissions. Editor, Reviewer, Approver of medical device design control documents spanning from RnD to market launch.
- Platomics GmbH,Performance Evaluation Manager & Regulatory Affairs ManagerSeptember 2021 - August 2022 (11 Monate)Vienna, AustriaGeneration, editing, review and maintenance of documents related to safety and performance evaluation of in vitro diagnostic medical devices.
- Children's Cancer Research Institute,Clinical Trial Project ManagerNovember 2020 - August 2021 (9 Monate)Vienna, AustriaLead and overseeing the planning, execution, and close-out of an international clinical trial.Coordination of internal and external stakeholders (CROs, investigational sites, investigators, vendors, Authorities, Ethics Committees)Providing trial master file – US FDA inspection readiness
Empfehlungen
Sei die erste Person, die Markus empfiehlt
Teile Deine Erfahrung aus der Zusammenarbeit mit diesem Freelancer.
Diese Freelancer passen auch zu Ihren Kriterien
Agatha Frydrych
Backend Java Software Engineer
4.7
(3)
2
Baptiste Duhen
Fullstack developer
4.6
(4)
5
Amed Hamou
Senior Lead Developer
4
(2)
7
Audrey Champion
Web developer
4.3
(3)
4
Ausbildung und Abschlüsse
- MBA studiesUniversity for Continuing Education Krems2025MBA studies
- PhD studiesLudwig Boltzmann Institute for Cancer Research2010PhD studies